Pharmstandard International’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
$3.67M Hold
565,063
12.65% 4
2018
Q2
$4.33M Sell
565,063
-97,000
-15% -$743K 17.36% 3
2018
Q1
$14.8M Hold
662,063
37.17% 1
2017
Q4
$8.44K Hold
662,063
8.68% 4
2017
Q3
$10.3M Hold
662,063
30.07% 2
2017
Q2
$9.29M Hold
662,063
32.21% 2
2017
Q1
$14.6M Buy
+662,063
New +$14.6M 38.85% 1